Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Svancarova L.   Blay J.Y.   Judson I.R.   van Hoesel Q.G.C.M.   van Oosterom A.T.   le Cesne A.   Keizer H.J.   Hermans C.   van Glabbeke M.   Verweij J.   Hogendoorn P.C.W.   Nielsen O.S.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 556-559

Elsevier

Access to resources Recommend Favorite

Phase II Study of Rapid-scheduled Etoposide in Paediatric Soft Tissue Sarcomas

By Phillips M.B.   Flamant F.   Sommelet-Olive D.   Pinkerton C.R.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 782-784

Elsevier

Access to resources Recommend Favorite

Phase II study of paclitaxel in patients with soft tissue sarcomas

By Patel Shreyaskumar R.   Linke Kaye A.   Burgess M. Andrew   Papadopoulos Nicholas E.   Plager Carl   Jenkins Jan   Benjamin Robert  

Sarcoma, Vol. 1, Iss. 2, 1997-06 ,pp. : 95-98

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults - long-term results of a phase II study

By Issels R.D.   Abdel-Rahman S.   Wendtner C.-M.   Falk M.H.   Kurze V.   Sauer H.   Aydemir U.   Hiddemann W.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1599-1608

Elsevier

Access to resources Recommend Favorite

Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults - results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia

By Wendtner C.-M.   Abdel-Rahman S.   Baumert J.   Falk M.H.   Krych M.   Santl M.   Hiddemann W.   Issels R.D.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1609-1616

Elsevier

Access to resources Recommend Favorite